Novel microhydroxyapatite particles in a collagen scaffold: A bioactive bone void filler?

Clinical Orthopaedics and Related Research

Volumn 472, Issue 4, 2014, Pages 1318-1328

  Lyons, Frank G ^a,b,c,d   Gleeson, John P ^a,b   Partap, Sonia ^a,b   Coghlan, Karen ^a,b   O'Brien, Fergal J ^a,b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c CAPPAGH NATIONAL ORTHOPAEDIC HOSPITAL   (Ireland)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; HYDROXYAPATITE; MICROHYDROXYAPATITE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BONE FILLER; BONE GRAFT; BONE RADIOGRAPHY; CONTROLLED STUDY; FEMALE; HEALING; HISTOLOGY; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOTOMY; PRIORITY JOURNAL; RADIUS;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; BONE SUBSTITUTES; BONE TRANSPLANTATION; COLLAGEN; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DURAPATITE; FEMALE; FRACTURE HEALING; GUIDED TISSUE REGENERATION; OSTEOTOMY; RABBITS; RADIUS; RADIUS FRACTURES; RECOMBINANT PROTEINS; TIME FACTORS; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 84896390054     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-013-3438-0     Document Type: Article

References (47)

1. Alam MI, Asahina I, Ohmamiuda K, Takahashi K, Yokota S, Enomoto S. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. Biomaterials. 2001;22:1643-1651.
2. Bauer TW, Muschler GF. Bone graft materials: an overview of the basic science. Clin Orthop Relat Res. 2000;371:10-27.
3. Boden SD, Zdeblick TA, Sandhu HS, Heim SE. The use of rhBMP-2 in interbody fusion cages: definitive evidence of osteoinduction in humans: a preliminary report. Spine (Phila Pa 1976). 2000;25:376-381.
4. Curtin CM, Cunniffe GM, Lyons FG, Bessho K, Dickson GR, Duffy GP, O'Brien FJ. Innovative collagen nano-hydroxyapatite scaffolds offer a highly efficient non-viral gene delivery platform for stem cell-mediated bone formation. Adv Mater. 2012;24:749-754.
5. Department of Health and Human Services, US. Agency for Healthcare Research and Quality report. Bone Morphogenetic Protein: The State of the Evidence for On-Label and Off-Label Use. Available at: http://www.ahrq.gov/ clinic/ta/comments/boneprotein/. Accessed 05/12/2011.
6. FDA Centers for Devices and Radiological Health. Corrspondence to RW Treharne and Premarket Approval Application (PMS) Supplement. Re: P000058. InFUSE™ Bone Graft/LT-CAGE™ Lumbar Tapered Fusion Device. Available at: http://www.accessdata.fda.gov/cdrh-docs/pdf/P000058a.pdf. Accessed May 12, 2011.
7. FDA Centers for Devices and Radiological Health. Summary of Safety and Effectiveness Data. Available at: http://www.accessdata.fda.gov/cdrh-docs/pdf/ P000058b.pdf. Accessed May 12, 2011.
8. FDA Centers for Devices and Radiological Health. Correspondence to AJ LaForte and Conditions of Approval for an HDE for OP-1™. Available at: http://www.accessdata.fda.gov/cdrh-docs/pdf/h010002a.pdf. Accessed May 12, 2011.
9. FDA. Centers for Devices and Radiological Health. Correspondence to D Ellis and Premarket Approval for INFUSE® bone graft. Available at: http://www.accessdata.fda.gov/cdrh-docs/pdf/p000054a.pdf. Accessed May 12, 2011.
10. Garrett MP, Kakarla UK, Porter RW, Sonntag VK. Formation of painful seroma and edema after the use of recombinant human bone morphogenetic protein-2 in posterolateral lumbar spine fusions. Neurosurgery. 2010;66:1044-1049; discussion 1049.
11. Gleeson JP, Plunkett NA, O'Brien FJ. Addition of hydroxyapatite improves stiffness, interconnectivity and osteogenic potential of a highly porous collagen-based scaffold for bone tissue regeneration. Eur Cell Mater. 2010;20:218-230.
12. Haugh MG, Jaasma MJ, O'Brien FJ. The effect of dehydrothermal treatment on the mechanical and structural properties of collagen-GAG scaffolds. J Biomed Mater Res A. 2009;89:363-369.
13. Hedberg EL, Kroese-Deutman HC, Shih CK, Crowther RS, Carney DH, Mikos AG, Jansen JA. In vivo degradation of porous poly(propylene fumarate)/poly(DL- lactic-co-glycolic acid) composite scaffolds. Biomaterials. 2005;26:4616-4623.
14. Jahangir AA, Nunley RM, Mehta S, Sharan A; Fellows at WHP. Bone-graft substitutes in orthopaedic surgery. AAOS Now. 2008;2:1-5.
15. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005;26:5474-5491.
16. Laurencin CT, Khan Y, El-Amin SF. Bone graft substitutes. Expert Rev Med Devices. 2006;3:49-57.
17. Le Nihouannen D, Daculsi G, Saffarzadeh A, Gauthier O, Delplace S, Pilet P, Layrolle P. Ectopic bone formation by microporous calcium phosphate ceramic particles in sheep muscles. Bone. 2005;36:1086-1093.
18. LeGeros RZ. Calcium phosphate-based osteoinductive materials. Chem Rev. 2008;108:4742-4753.
19. Lyons FG, Al-Munajjed AA, Kieran SM, Toner ME, Murphy CM, Duffy GP, O'Brien FJ. The healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructs. Biomaterials. 2010;31:9232-9243.
20. McKay B, Sandhu HS. Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications. Spine (Phila Pa 1976). 2002;27(16 suppl 1):S66-85.
21. Murphy CM, Haugh MG, O'Brien FJ. The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials. 2010;31:461-466.
22. O'Brien FJ, Harley BA, Yannas IV, Gibson L. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. Biomaterials. 2004;25:1077-1086.
23. O'Brien FJ, Harley BA, Yannas IV, Gibson LJ. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials. 2005;26:433-441.
24. O'Brien FJ, Plunkett NA, Gleeson JP, inventors: A collagen/hydroxyapatite composite scaffold, and process for the production thereof. US patent US8435552 (B2)-2013-05-07; European patent EP2117617 (B1)-2013-08-1; Australia patent AU2008212526 (A1).
25. Perry CR. Bone repair techniques, bone graft, and bone graft substitutes. Clin Orthop Relat Res. 1999;360:71-86.
26. Ratko TA, Belinson SE, Samson DJ, Bonnell C, Ziegler KM, Aronson N. Bone morphogenetic protein: the state of the evidence of on-label and off-label use. Technology Assessment Report. Available at: http://www.cms.gov/ DeterminationProcess/downloads/id75ta.pdf?bcsi-scan-9CF786ACA806128D= 0&bcsi-scan-filename=id75ta.pdf. Accessed May 12, 2011.
27. Roy TD, Simon JL, Ricci JL, Rekow ED, Thompson VP, Parsons JR. Performance of degradable composite bone repair products made via three-dimensional fabrication techniques. J Biomed Mater Res A. 2003;66:283-291.
28. Schuessele A, Mayr H, Tessmar J, Goepferich A. Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces. J Biomed Mater Res A. 2009;90:959-971.
29. Sciadini MF, Johnson KD. Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model. J Orthop Res. 2000;18:289-302.
30. Seeherman H, Wozney J, Li R. Bone morphogenetic protein delivery systems. Spine (Phila Pa 1976). 2002;27(16 suppl 1):S16-23.
31. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976). 2006;31:542-547.
32. Smucker JD, Petersen EB, Fredericks DC. Assessment of MASTERGRAFT PUTTY as a graft extender in a rabbit posterolateral fusion model. Spine (Phila Pa 1976). 2012;37:1017-1021.
33. Tierney CM, Haugh MG, Liedl J, Mulcahy F, Hayes B, O'Brien FJ. The effects of collagen concentration and crosslink density on the biological, structural and mechanical properties of collagen-GAG scaffolds for bone tissue engineering. J Mech Behav Biomed Mater. 2009;2:202-209.
34. Tuli SM, Gupta KB. Bridging of large chronic osteoperiosteal gaps by allogeneic decalcified bone matrix implants in rabbits. J Trauma. 1981;21:894-898.
35. Urist MR. Bone: formation by autoinduction. Science. 1965;150:893-899.
36. Vaidya R. Transforaminal interbody fusion and the "off label" use of recombinant human bone morphogenetic protein-2. Spine J. 2009;9:667-669.
37. Vines JB, Lim DJ, Anderson JM, Jun HW. Hydroxyapatite nanoparticle reinforced peptide amphiphile nanomatrix enhances the osteogenic differentiation of mesenchymal stem cells by compositional ratios. Acta Biomater. 2012;8:4053-4063.
38. Wakimoto M, Ueno T, Hirata A, Iida S, Aghaloo T, Moy PK. Histologic evaluation of human alveolar sockets treated with an artificial bone substitute material. J Craniofac Surg. 2011;22:490-493.
39. Williams DF. On the nature of biomaterials. Biomaterials. 2009;30:5897-5909.
40. Wong DA, Kumar A, Jatana S, Ghiselli G, Wong K. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J. 2008;8:1011-1018.
41. Yannas IV, Burke JF. Design of an artificial skin: I. Basic design principles. J Biomed Mater Res. 1980;14:65-81.
42. Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH. Design of an artificial skin: II. Control of chemical composition. J Biomed Mater Res. 1980;14:107-132.
43. Yannas IV, Lee E, Orgill DP, Skrabut EM, Murphy GF. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci U S A. 1989;86:933-937.
44. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2): a radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am. 1992;74:659-670.
45. Yuan H, De Bruijn JD, Zhang X, Van Blitterswijk CA, De Groot K. Use of an osteoinductive biomaterial as a bone morphogenetic protein carrier. J Mater Sci Mater Med. 2001;12:761-766.
46. Yuan H, Fernandes H, Habibovic P, de Boer J, Barradas A, de Ruiter A, Walsh W, van Blitterswijk C, de Bruijn J. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc Natl Acad Sci U S A. 2010;107:13614-13619.
47. Yuan H, Van Den Doel M, Li S, Van Blitterswijk CA, De Groot K, De Bruijn JD. A comparison of the osteoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats. J Mater Sci Mater Med. 2002;13:1271-1275.